In addition to the potential use of FAM83A as a biomarker, a forward genetic screen identified FAM83A as a driver of EGFR tyrosine kinase inhibitor (TKI) resistance, suggesting FAM83A plays an important role in cancer cell biology [25]. This evidence concerns the gene SACK1A and cancer.